Cargando…

Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting

Objective: The objectives of this study were to ascertain the acceptance rate of human immunodeficiency virus type 1 (HIV-1) testing in a high-prevalence area and to describe the sociodemographic and clinical characteristics of seropositive women diagnosed in the prenatal setting. Methods: A retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardeguez, Arlene D., Denny, Thomas, Palumbo, Paul, Wesley, Yvonne, Oleske, James, Connor, Edward, Weiss, Gerson
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364442/
https://www.ncbi.nlm.nih.gov/pubmed/18476047
http://dx.doi.org/10.1155/S106474499500069X
_version_ 1782153955410706432
author Bardeguez, Arlene D.
Denny, Thomas
Palumbo, Paul
Wesley, Yvonne
Oleske, James
Connor, Edward
Weiss, Gerson
author_facet Bardeguez, Arlene D.
Denny, Thomas
Palumbo, Paul
Wesley, Yvonne
Oleske, James
Connor, Edward
Weiss, Gerson
author_sort Bardeguez, Arlene D.
collection PubMed
description Objective: The objectives of this study were to ascertain the acceptance rate of human immunodeficiency virus type 1 (HIV-1) testing in a high-prevalence area and to describe the sociodemographic and clinical characteristics of seropositive women diagnosed in the prenatal setting. Methods: A retrospective review was carried out of the prenatal HIV-1 counseling and testing program at University Hospital, Newark, NJ (1989-1990). Results: Sixty-seven percent (741/1,114) of the women offered HIV-1 counseling services accepted testing and 40 (40/741:5.3%) new cases were identified. Heterosexual contact was the primary exposure (17:52%) of these women, of whom 13 (73%) had negative syphilis serologies. Sixty-four percent were asymptomatic. The mean absolute CD4 lymphocyte count in seropositive women was 514 ± 305 cells/mm(3) . Severe immunosuppression was seen in 7/32 (22%) patients. Seventy-three percent (24/33) depended on public-assistance programs for their health-care services. Conclusions: A voluntary HIV-1 counseling and testing program is well accepted in the prenatal setting. It can provide early identification of asymptomatic seropositive women and infants at risk and lead to early intervention and therapy.
format Text
id pubmed-2364442
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-23644422008-05-12 Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting Bardeguez, Arlene D. Denny, Thomas Palumbo, Paul Wesley, Yvonne Oleske, James Connor, Edward Weiss, Gerson Infect Dis Obstet Gynecol Research Article Objective: The objectives of this study were to ascertain the acceptance rate of human immunodeficiency virus type 1 (HIV-1) testing in a high-prevalence area and to describe the sociodemographic and clinical characteristics of seropositive women diagnosed in the prenatal setting. Methods: A retrospective review was carried out of the prenatal HIV-1 counseling and testing program at University Hospital, Newark, NJ (1989-1990). Results: Sixty-seven percent (741/1,114) of the women offered HIV-1 counseling services accepted testing and 40 (40/741:5.3%) new cases were identified. Heterosexual contact was the primary exposure (17:52%) of these women, of whom 13 (73%) had negative syphilis serologies. Sixty-four percent were asymptomatic. The mean absolute CD4 lymphocyte count in seropositive women was 514 ± 305 cells/mm(3) . Severe immunosuppression was seen in 7/32 (22%) patients. Seventy-three percent (24/33) depended on public-assistance programs for their health-care services. Conclusions: A voluntary HIV-1 counseling and testing program is well accepted in the prenatal setting. It can provide early identification of asymptomatic seropositive women and infants at risk and lead to early intervention and therapy. Hindawi Publishing Corporation 1995 /pmc/articles/PMC2364442/ /pubmed/18476047 http://dx.doi.org/10.1155/S106474499500069X Text en Copyright © 1995 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bardeguez, Arlene D.
Denny, Thomas
Palumbo, Paul
Wesley, Yvonne
Oleske, James
Connor, Edward
Weiss, Gerson
Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting
title Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting
title_full Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting
title_fullStr Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting
title_full_unstemmed Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting
title_short Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting
title_sort human immunodeficiency virus type 1 counseling and testing program in the prenatal setting
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364442/
https://www.ncbi.nlm.nih.gov/pubmed/18476047
http://dx.doi.org/10.1155/S106474499500069X
work_keys_str_mv AT bardeguezarlened humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting
AT dennythomas humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting
AT palumbopaul humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting
AT wesleyyvonne humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting
AT oleskejames humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting
AT connoredward humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting
AT weissgerson humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting